Cochrane Abstracts
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phosphodiesterase Inhibitors for Lower Urinary Tract Symptoms Consistent With Benign Prostatic Hyperplasia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439735/all/Phosphodiesterase_inhibitors_for_lower_urinary_tract_symptoms_consistent_with_benign_prostatic_hyperplasia.
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/all/Phosphodiesterase_inhibitors_for_lower_urinary_tract_symptoms_consistent_with_benign_prostatic_hyperplasia. Accessed March 27, 2025.
Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/all/Phosphodiesterase_inhibitors_for_lower_urinary_tract_symptoms_consistent_with_benign_prostatic_hyperplasia
Phosphodiesterase Inhibitors for Lower Urinary Tract Symptoms Consistent With Benign Prostatic Hyperplasia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/all/Phosphodiesterase_inhibitors_for_lower_urinary_tract_symptoms_consistent_with_benign_prostatic_hyperplasia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
ID - 439735
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439735/all/Phosphodiesterase_inhibitors_for_lower_urinary_tract_symptoms_consistent_with_benign_prostatic_hyperplasia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
